Jie Li

Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.

Yuan-Lin Guo, Jian‐Jun Li, C. Xiong, 2010, Cardiovascular therapeutics.

Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.

B. Xu, Jian‐Jun Li, X. Qin, 2007, Clinica chimica acta; international journal of clinical chemistry.

Elevated circulating inflammatory markers in female patients with cardiac syndrome X.

Jian‐Jun Li, X. Qin, Zhan Gao, 2007, Cytokine.

Is any link between inflammation and coronary artery ectasia?

Jian‐Jun Li, Jian-jun Li, Zheng Li, 2007, Medical hypotheses.

Angiographic prevalence of myocardial bridging in a defined very large number of Chinese patients with chest pain.

B. Xu, S. Qiao, Jin-qing Yuan, 2008, Chinese medical journal.

Nuclear factor‐κB in rheumatoid arthritis

Jie Li, Jin-Qi Li, R. Tang, 2020, International journal of rheumatic diseases.

Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina

Jian‐Jun Li, Chao-yang Zhang, H. Zeng, 2008, Coronary artery disease.

A rational connection of inflammation with peripheral arterial disease.

Jian‐Jun Li, Jie Li, H. Qian, 2007, Medical hypotheses.